173 related articles for article (PubMed ID: 15840687)
1. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer.
Cacev T; Radosević S; Spaventi R; Pavelić K; Kapitanović S
Gut; 2005 Aug; 54(8):1129-35. PubMed ID: 15840687
[TBL] [Abstract][Full Text] [Related]
2. nm23-H1 expression and loss of heterozygosity in colon adenocarcinoma.
Kapitanović S; Cacev T; Berković M; Popović-Hadzija M; Radosević S; Seiwerth S; Spaventi S; Pavelić K; Spaventi R
J Clin Pathol; 2004 Dec; 57(12):1312-8. PubMed ID: 15563674
[TBL] [Abstract][Full Text] [Related]
3. Multiple transcripts of the neurofibromatosis type 1 gene in human brain and in brain tumours.
Takahashi K; Suzuki H; Kayama T; Suzuki Y; Yoshimoto T; Sasano H; Shibahara S
Clin Sci (Lond); 1994 Nov; 87(5):481-5. PubMed ID: 7874833
[TBL] [Abstract][Full Text] [Related]
4. The neurofibromin 1 type I isoform predominance characterises female population affected by sporadic breast cancer: preliminary data.
Marrero D; Peralta R; Valdivia A; De la Mora A; Romero P; Parra M; Mendoza N; Mendoza M; Rodriguez D; Camacho E; Duarte A; Castelazo G; Vanegas E; Garcia I; Vargas C; Arenas D; Jimenez F; Salcedo M
J Clin Pathol; 2012 May; 65(5):419-23. PubMed ID: 22412049
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity.
Karvonen SL; Koivunen J; Nissinen M; Ylä-Outinen H; Björkstrand AS; Peltonen J
Br J Dermatol; 2004 Feb; 150(2):211-9. PubMed ID: 14996090
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient.
Perren A; Wiesli P; Schmid S; Montani M; Schmitt A; Schmid C; Moch H; Komminoth P
Am J Surg Pathol; 2006 Aug; 30(8):1047-51. PubMed ID: 16861979
[TBL] [Abstract][Full Text] [Related]
7. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.
Kapitanović S; Cacev T; Radosević S; Spaventi S; Spaventi R; Pavelić K
Exp Mol Pathol; 2004 Dec; 77(3):193-200. PubMed ID: 15507235
[TBL] [Abstract][Full Text] [Related]
8. Loss of neurofibromatosis type I (NF1) gene expression in pheochromocytomas from patients without NF1.
Gutmann DH; Geist RT; Rose K; Wallin G; Moley JF
Genes Chromosomes Cancer; 1995 Jun; 13(2):104-9. PubMed ID: 7542904
[TBL] [Abstract][Full Text] [Related]
9. Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development.
Gutmann DH; Cole JL; Collins FS
Prog Brain Res; 1995; 105():327-35. PubMed ID: 7568895
[TBL] [Abstract][Full Text] [Related]
10. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.
Gutmann DH; Donahoe J; Brown T; James CD; Perry A
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):361-7. PubMed ID: 10931370
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma.
Gutzmer R; Herbst RA; Mommert S; Kiehl P; Matiaske F; Rütten A; Kapp A; Weiss J
Hum Genet; 2000 Oct; 107(4):357-61. PubMed ID: 11129335
[TBL] [Abstract][Full Text] [Related]
12. Loss of NF2/Merlin expression in advanced sporadic colorectal cancer.
Cačev T; Aralica G; Lončar B; Kapitanović S
Cell Oncol (Dordr); 2014 Feb; 37(1):69-77. PubMed ID: 24323642
[TBL] [Abstract][Full Text] [Related]
13. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression.
Cacev T; Radosević S; Krizanac S; Kapitanović S
Carcinogenesis; 2008 Aug; 29(8):1572-80. PubMed ID: 18628251
[TBL] [Abstract][Full Text] [Related]
14. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of NF1 type I and type II isoforms in sporadic borderline and invasive epithelial ovarian tumors.
Iyengar TD; Ng S; Lau CC; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1999 Jan; 18(1):257-62. PubMed ID: 9926941
[TBL] [Abstract][Full Text] [Related]
17. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
[TBL] [Abstract][Full Text] [Related]
19. The two types of mRNAs for neurofibromin isoforms produced by von Recklinghausen neurofibromatosis (NF1) gene: analysis in human astrocytic tumors.
Tokuyama T; Uemura K; Fujita M
Neurosci Lett; 1995 Aug; 196(3):189-92. PubMed ID: 7501280
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutations in the neurofibromatosis 1 gene in human tumors.
Li Y; Bollag G; Clark R; Stevens J; Conroy L; Fults D; Ward K; Friedman E; Samowitz W; Robertson M
Cell; 1992 Apr; 69(2):275-81. PubMed ID: 1568247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
